Spinal Muscular Atrophy (SMA) is a major inherited cause of infant death worldwide.
Introduction
Spinal muscular atrophy (SMA) is an inherited, monogenic condition, resulting from homozygous deletion of the survival of motor neuron (SMN1) gene 1 . The gene was originally named a the assumption that it is specifically required for maintenance and survival of motor neurons, thereby explaining the primary lower motor neuron-associated phenotypes of affected children. In addition, many recent studies have highlighted the importance of SMN protein for the normal development and maintenance of a range of other cell types, tissues and organs in SMA. What is particularly striking, is the discovery of widespread tissue and organ pathology beyond the neuromuscular system 2, 3 . These systemic pathologies may manifest sub--clinically in human SMA patients 4, 5 . However, similar defects have been unmasked when therapies specifically targeting the motor system resulted in significant improvement of motor skills, but failed to rescue overall disease severity in SMA mice 6--8 . Furthermore, recent work using peripherally--targeted rescue strategies has demonstrated that therapies which specifically do not modulate SMN protein levels in the central nervous system (CNS) are still able to significantly ameliorate disease severity in SMA mice 9, 10 .
The role that the cardiovascular system, and blood vessels in particular, plays in SMA pathogenesis remains unclear. However, cardiac defects have been described in SMA patients as well as animal models 4, 5, 11 , and disrupted capillary networks are reported in skeletal muscle from SMA mice 12 . Moreover, vascular defects have been linked to the pathogenesis of other neurodegenerative conditions such as Alzheimer's disease 13 , and diseases where motor neurons are targeted, such as amyotrophic lateral sclerosis (ALS) 14 . Such serious and significant defects in the capillary bed are likely to impact upon the delivery of oxygen to tissues, and potentially also to the development and function of myriad systems in the body.
Whether damage to the vasculature and microcirculation within the spinal cord occurs in SMA remains unknown. Here, we combined analysis of established mouse models of severe forms of SMA with muscle biopsies from severe SMA patients to address these questions.
Materials and Methods
Mice: 'Taiwanese' SMA mice (Jackson Labs strain no. 005058) on a congenic FVB background were maintained as breeding pairs (Smn +/-x Smn --/--;SMN2 tg/tg ) pairs under standard SPF conditions in animal care facilities in Edinburgh. Offspring were either homozygous knockout for endogenous Smn (Smn --/--;SMN2 tg/0 ), referred to as SMA or heterozygous for Smn knockout (Smn +/--;SMN2 tg/0 ), referred to as 'Control'. SMA mice therefore carry two SMN2 copies on one allele on a null murine Smn background 15 . Retrospective genotyping for this strain was carried out using standard PCR protocols 16 . 'Delta 7' SMA mice on a congenic FVB background were maintained as heterozygous SMN2 +/+ ;SMN2Δ7 +/+ ;Smn +/--(Jackson labs strain no. 005025) breeding pairs.
Offspring were either; Smn KO: SMN2 +/+ ;SMNΔ7 +/+ ;Smn −/− , referred to as 'SMA' or Smn heterozygous; SMN2 +/+ ;SMNΔ7 +/+ ;Smn +/− , referred to as 'Control'. Some offspring are homozygous wild--type for Smn and were not used in the study. Mice were maintained in animal care facilities and genotyped in Oxford as previously reported 17 . In each case the morning of the day on which a litter was found was designated P0. All animal procedures and breeding were performed under licensed authority of the UK Home Office, and in accordance with local institutional guidelines.
Taiwanese SMA--affected mice are first distinguishable from control littermates at P6/7 by reduction in weight and early weakness. They are typically sacrificed at the humane endpoint of P10--11 due to severe paralysis. Delta 7 SMA--affected mice are first distinguishable from control littermates at P7 by reduction in weight and early weakness. They are typically sacrificed at the humane endpoint of P13--15 due to severe paralysis.
Mouse tissue collection:
Male and female offspring were utilised in this study, as preliminary work indicated no differences between the sexes. All mice were sacrificed by intraperitoneal injection of sodium pentobarbital. Whole spinal cord-containing vertebral columns and proximal forelimbs were rapidly dissected and fixed in 0.1M phosphate buffered saline (PBS) containing 4% paraformaldehyde.
Tissue was cryoprotected in a 50:50 solution of OCT and 30% sucrose prior to freezing on dry ice. Sections were cut at 10 µm from the proximal forelimbs (shoulder to elbow) and thoracic vertebral column at 14µm on a cryostat (3080 LeicaCM). Sections were selected at regular intervals from each for immunohistochemical analysis.
SMA patient and control individual skeletal muscle biopsies:
Studies on muscle biopsies from SMA patients (age range 1--34 months old, n=7) and control patients (age range 0.3--36 months old, n=9) were approved by the NRES Committee East of England Institutional Ethical Committee and conducted under the Declaration of Helsinki. Patients' personal information was encoded to protect their identity, and written informed consent obtained by the patient or the responsible guardian. All patients presented in this study have a clear clinical and pathological diagnosis of SMA (data not shown). Control muscle biopsies were from individuals with no neuromuscular or vascular diseases.
Patient biopsy immunohistochemistry
Cryosections from muscle biopsies were cut at a thickness of 7 μm for immunohistochemistry. Muscle fibres were stained with rabbit polyclonal anti--Laminin primary antibody (Sigma L9393: 1:200) and blood vessels in muscle biopsies were stained with mouse monoclonal anti--CD31/ PECAM--1 primary antibody (SeroTec MCA1738: 1:100). Double staining of Laminin and CD31/ PECAM--1 was visualized with Alexa Fluor 488 goat anti--Rabbit IgG (H+L) and Alexa Fluor 594 goat anti--Mouse IgG (H+L) (Life Technologies: 1:500). Sections were mounted in Hydromount mounting medium (National Diagnostics, England). Images were digitally captured using Metamorph software.
Mouse immunohistochemistry: Muscle sections from throughout the proximal forelimb were stained with Rhodamine--labelled Griffonia simplicifolia Lectin--1 (GSL--1: Vector Laboratories RL--1102: 1:100) to label the capillary bed. Some sections were double labeled with rabbit polyclonal anti--alpha smooth muscle Actin primary antibody (a--SMActin: abcam ab5694: 1:250), visualized with fluorescein--labelled polyclonal swine anti--rabbit immunoglobulin (Jackson ImmunoResearch Laboratories Inc.: 1:40) to stain smooth muscle and mounted in Mowiol.
Spinal cord sections were stained with goat anti--mouse PECAM--1 primary antibody (R&D Systems AF3628 at 1:750). After washing, slides were incubated with donkey anti--goat Cy3--conjugated secondary antibody (Jackson ImmunoResearch Laboratories Inc. at 1:250). After PECAM--1 staining, some slides were incubated overnight in SMI--32 primary antibody (a gift from Professor Siddharthan Chandran, University of Edinburgh) at 1:500 and visualized with donkey anti--mouse Alexafluor 488--conjugated secondary antibody (Dako) at 1:250. Slides were then washed and mounted as above.
Additional spinal cord sections were stained with, either rabbit anti--mouse aquaporin--4 (AQ--4: Abcam ab125049), rabbit anti--mouse claudin--5 (CL--5: Abcam ab59720) or rabbit anti--mouse zona occludens--1 (ZO--1: Abcam ab53765) primary antibodies, all at a concentration of 1:100. Each was visualized with a swine anti-rabbit FITC--conjugated secondary antibody (Dako: 1:40). Following this, capillaries were labeled with GSL--1, as described above.
Labeling of hypoxic tissue with pimonidazole hydrochloride
Entire litters of P5 Taiwanese severe model SMA mice were injected with the hypoxia marker pimonidazole hydrochloride (PIMO). PIMO diffuses effectively in tissue including the CNS 18 , is retained in hypoxic cells, and can be labeled with antibodies to mark neurons in experimental hypoxia 19 .
A single 60mg/kg dose of PIMO was administered via intraperitoneal (IP) injection.
After injection mice were returned to their cage with their parents for 1 hr, during which time the mice were closely monitored. In this hour, PIMO was delivered systemically to all body tissues via the bloodstream. In mice, PIMO has a plasma half-life of 25 min 20 , and is cleared by the kidneys 18 . Thus, experimental durations of an hour or longer between injection and sacrifice allow for the systemic distribution of PIMO and its subsequent clearance from the plasma. 90 min after PIMO injection, Taiwanese SMA mice and control littermates were sacrificed by an overdose of anaesthetic administered via IP injection of sodium pentabarbitol (Euthenal). Mice were sacrificed in the order they were initially injected with PIMO. Each injection was timed to ensure that each animal was exposed to PIMO for an equal amount of time and given the same time to clear residual unbound PIMO from the plasma. At the time of tissue collection, PIMO will already be bound to proteins in any hypoxic cells in the body tissues. During harvesting, tissue becomes anoxic, but the very low levels of PIMO remaining in the plasma at the time of collection should prevent any PIMO binding as a result of dissection anoxia. To further ensure this, dissections of spinal cord were performed rapidly with tissues being collected and fixed in <5 min.
Nissl co--staining was also carried out on sections, to identify grey and white matter regions of the spinal cord, using a 0.2% solution of cresyl fast violet (CFV).
Imaging and Quantification
All images were captured using a chilled CCD camera (Hammamatsu C4742--95) using OpenLab image capture software on an Olympus IX71 microscope. Muscle capillary density (human): was analysed from 3--9 (mean=5) non--consecutive sections per muscle biopsy, which were photographed at x40 magnification and quantified to calculate C:F ratio as indicated above for mouse.
Statistical analysis: All data were collected using Microsoft Excel software. Graphs were generated and statistical analyses performed using GraphPad Prism software.
Bar charts represent mean ± s.e.m. and scatter plots show data points and mean values. Statistical significance was considered to be p<0.05. Statistical tests used are detailed in the figure legends.
Results
Given the evidence for pathology outside the nervous system in SMA, we investigated the vascular system and specifically the capillary bed of clinically-relevant, proximal skeletal muscles and spinal cord in mice and skeletal muscle biopsies from type 1 SMA patients. We set out to determine if blood supply to motor nerve terminals in skeletal muscle or motor neuron cell bodies in spinal cord is compromised and therefore potentially significant in the aetiology of SMA.
Vasculature is aberrant in post--natal SMA proximal skeletal muscle
First, we extended previous studies detailing significant defects in muscle capillaries in trunk muscles 12 , by demonstrating that there are parallel significant vascular defects in clinically--relevant, proximal, forelimb muscles at a symptomatic time--point (P8) in the Taiwanese mouse model of severe SMA.
A marked decrease in the density of intra--muscular capillaries (GSL--1 staining) was immediately apparent in transverse sections of multiple, individual skeletal muscles from proximal forelimbs in SMA mice ( Fig 1A,B ) compared with control littermates.
As a percentage of cross sectional area, muscle from SMA mice was less than half as capillary--dense as control littermates ( Fig 1C) . Closer observation showed that many muscle fibers were no longer adjacent to capillaries in SMA muscles ( Fig 1B) .
Therefore we next calculated the number of capillary profiles per muscle fiber profile, which is perhaps a more informative functional measure of perfusion distances and controls for bias introduced by variations in muscle fiber diameter, as occur in neuromuscular wasting diseases such as SMA. The capillary/muscle fiber ratio in SMA mice was only 40% of that in control littermates ( Fig 1D) , confirming skeletal muscle hypovascularity in SMA. Larger arterioles, identified as α--Smooth
Muscle Actin--(α -SMA) expressing vessels, appeared morphologically normal and mature We then checked if these intra--muscular arterioles were structurally normal and the mean caliber of intramuscular arterioles was not significantly different between SMA: 1.90µm and littermate control: 1.64µm mice, (NS P>0.05 unpaired, two--tailed t--test) and mature, as the ratio of vessel caliber (v) to the surrounding smooth muscle diameter (m) v/m was not significantly different between SMA:
0.738 and control littermate: 0.753 mice, (NS P>0.05 unpaired, two--tailed t--test) but were reduced in number in SMA mice: 57% compared to control littermates ( Fig 1E) .
Thus, there were significantly fewer capillaries (small vessels including arterioles and venules) and fewer larger and mature, intramuscular arterioles in clinically--relevant, proximal forelimb muscles in Taiwanese severe SMA mice at a symptomatic time-point. Therefore, diffusion distances were increased and perfusion to muscle fibers and motor nerve terminals was likely compromised.
Aberrant vasculature is also present in skeletal muscle from human SMA patients
We were particularly interested to determine if similar vascular changes were present in SMA patients. To this end skeletal muscle biopsies from 7 type I/II patients and 9 controls were obtained, immunostained and analysed in an identical manner to the mouse samples. As was seen in mouse models, there were no differences in vascularity immediately after birth, but with increasing development, dramatic discrepancies became apparent. Muscle from control children showed a steady increase in C:F ratio from 0.1:1 at 0.5 months to 0.8:1 at 36 months (Fig 2A,C) , which approaches a mature ratio of >1.0:1 21, 22 . In contrast, biopsies from Type I/II severe patients showed a failure to develop beyond the situation at birth, with a ratio of 0.09:1 at 1 month and 0.08:1 at 33 months (Fig 2A,C) . By 33/36 months of age there was a tenfold difference in capillary: fibre ratio between control and SMA muscle biopsies. Regression analysis of the data shows a clear and significant diference in the rate of vascularisation between control and SMA biopsies ( Fig 2C) .
This results in muscle fibres being much more distant from capillaries at 33/36 months in SMA compared with control muscles ( Fig 2B) .
These data demonstrate comparable vascular defects, and in particular an apparent falure to develop significantly after birth in severe SMA patients, directly analagous to those described in severe mouse models of SMA.
Post--natal development of spinal cord vasculature in wild--type mice
We next turned our attention to the spinal cord, in order to establish whether the loss of motor neuron cell bodies that occurs in SMA also correlates with vascular changes. Surprisingly, post--natal development of spinal cord vasculature in the mouse has not been consistently or clearly described in the literature. Therefore, we first established the normal parameters for capillary development in the post--natal spinal cord of wild--type C57Bl mice to establish baseline data. In very young animals and as a percentage of spinal cord cross--sectional area, capillaries were sparse (P3), but progressively increased in density ( Fig 3A) and caliber ( Fig 3B) during the first 3
weeks of post--natal development. Capillary density in the grey and white matter was similar at P3, began to increase in grey matter at P7, was significantly greater by P14, and was more than double that in white matter by P21 ( Fig 3C) . Over this 3 week period, capillary density had doubled in white matter and quadrupled in grey matter.
In summary, capillaries were initially sparse in the early post--natal mouse spinal cord, but equally distributed throughout grey and white matter regions. There was a subsequent significant increase in both the size and ramification of capillaries during the first 3 weeks of post--natal development, superseding the growth of the spinal cord, and was most notable in grey matter (where motor neuron cell bodies are located).
Capillary density in spinal cord is dramatically decreased in Taiwanese SMA mice
When we repeated the analyses of spinal cord vasculature on litters of Taiwanese SMA mice, it was immediately apparent, from images of stained capillaries in whole spinal cord, that there was a marked decrease in capillary density in SMA compared to control littermates at P11. At this late symptomatic stage, capillaries were still sparse in the spinal cord of SMA mice, leaving considerable distances between neighboring vessels. Little of the expected differentiation between white and grey matter was apparent in SMA mice compared to that observed in littermate control mouse spinal cords ( Fig 4A,B) , including the ventral grey horn. This finding suggested that capillary density had not significantly increased in the region of spinal cord containing lower motor neuron cell bodies over this period in SMA. A subsequent temporal analysis revealed that capillaries were equally sparse in both SMA and control mouse spinal cords at birth, and had not increased in SMA by P5, resulting in a significantly hypovascular appearance ( Fig 4C) . By P11, SMA spinal cords were less than half as capillary--dense as control littermates ( Fig 4C) , with segmentation of dorsal and ventral grey and white matter revealing that all territories of the spinal cord were similarly depleted ( Fig 4D--G) .
In summary, capillary density did not increase in SMA mouse spinal cord between P3
(pre--symptomatic) and P11 (late--symptomatic) stages. Capillary growth in mouse spinal cord occurs by sprouting angiogenesis, suggesting a defect in this process when SMN levels are reduced. Such post--natal developmental hypovascularity would likely lead to increased diffusion distances between capillaries and motor neurons in the ventral grey horn.
Significant vascular deficiency of spinal cord is replicated in a second mouse model of severe SMA
We were keen to determine if these significant vascular defects were epiphenomena specific to SMN gene manipulation in the Taiwanese SMA model mouse, or rather represented a common feature of neuromuscular pathology in mouse models of severe SMA. Therefore, we turned to another commonly used and well characterized mouse model of SMA (Δ7 mice 23 ). We chose P14 as a direct comparison with the P11 data from the Taiwanese model, representing a late symptomatic time--point 3, 24--26 . In these slightly older mice the differential capillary density between grey and white matter is more apparent in both control and SMA spinal cords. Capillary density was quantified in an identical manner, and significant decreases were seen in each region and territory of the spinal cord in SMA compared to littermate controls (data not shown). Pooling the data for all regions,
for this second mouse model of severe SMA, we found the same pronounced and significant decrease in capillary density in SMA spinal cord ( Fig 4H--J) . In fact the relative capillary density in P14 Δ7 mice is remarkably similar to that in the younger P11 Taiwanese mice. In each case this density appears to have been maintained and to not have increased since the early post--natal period.
Taken together, these data suggest that a Fig 5D) .
In summary, spinal cord, and in particular lower motor neuron soma, were hypoxic at early symptomatic time--points in severe SMA mice. This finding demonstrates that the depleted vasculature phenotype in SMA mice leads to functional hypoxia in clinically--relevant tissue and may therefore provide an additional pathway through which the neuromuscular system is rendered vulnerable in SMA.
The blood--spinal cord barrier is defective in SMA mice
Hypoxia will have direct effects upon motor neurons, but in addition may result in secondary changes in spinal cord, which could further damage motor neurons.
Hypoxia can trigger changes in the blood brain barrier (BBB) 29 , and leaky BBB and blood spinal cord barriers (BSCB) have been shown to lead to direct damage of motor neurons 30 . Therefore we set out to determine if the BSCB showed any signs of damage in SMA spinal cord 31 . We examined 3 core elements of the BSCB; the tight--junctional proteins claudin--5 (CL--5) and zona occludens--1 (ZO--1) found on endothelial cells, and the water transporter aquaporin--4 (AQ--4) found on astrocytes.
At P11, ZO--1 was closely co--localised with GSL--1 positive blood vessels, and AQ--4
was also associated with all vessels examined in SMA mouse spinal cord. In contrast, CL--5 showed a very heterogeneous distribution in SMA mice. Here, many vessels showed close co--localisation, but many were negative for CL--5 ( Fig 6) . Given that hypoxia is known to affect CL--5 accumulation, we suggest that these changes in the BSCB occur downstream of spinal cord hypoxia. It is therefore likely, that an incomplete BSCB barrier will further amplify motor neuron damage in SMA.
In summary the BSCB was impaired in SMA mouse spinal cord, thereby identifying an additional, indirect and negative consequence of abnormal vascular development, that could contribute directly to motor neuron pathology in SMA.
Discussion
We can no longer view SMA as a disease that solely and specifically affects 'vulnerable' motor neurons. Evidence now points to significant systemic defects in SMA, but as both motor neurons and skeletal muscles are early and key targets of SMA, we need to better understand how SMN--depletion within these cell types can impact on the development and survival of the neuromuscular system.
This study has revealed significant defects in the development and post--natal maturation of capillary beds in SMA disease--relevant, proximal skeletal muscle and spinal cord in the first couple of post--natal weeks in severe SMA mice. Importantly, we show that similar vascular defects are also present in severe SMA patient muscle biopsies. Significantly, we build on these findings to demonstrate that vascular defects in SMA lead to in vivo hypoxia of spinal cord (including lower motor neuron soma) at an early symptomatic time--point. In addition to the gross defects in vascular development, defects in key BSCB proteins are also present in SMA mouse spinal cord. Given the known sensitivity of lower motor neurons to hypoxia in vivo 32 , these findings highlight a novel link between systemic vascular pathology and the particular vulnerability of the neuromuscular system in SMA. This novel description of vascular defects in severe forms of SMA, suggests that therapeutic targeting of the vascular system in order to ameliorate functional hypoxia and BSCB defects is likely to be required in order to deliver a systemic rescue of SMA.
Skeletal muscle capillary beds fail to develop normally in the early post--natal period
In SMA proximal skeletal muscle, capillary density, calculated using either a measure of capillary density per unit area or number of capillaries per muscle fiber profile, was less than half that in control littermates (Fig 1C,D) . Diffusion distances were therefore increased and many individual fibers were no longer immediately adjacent to a capillary ( Fig 1B) . The number of small, presumed angiogenic, capillaries was most severely affected, but larger, intramuscular arterioles expressing α--SMActin appeared to some extent spared in skeletal muscle ( Fig 1E) . We have previously shown that skeletal muscle capillary beds appear normal at birth 12 , suggesting that vessels present at birth remain, mature normally, and are largely unaffected by disease progression, but that small vessels undergoing active angiogenesis as the animal grows, are most affected. Most importantly, the capillary bed is severely compromised and diffusion distances to both muscle fibers and nerve terminals at neuromuscular junctions are increased. We have previously shown that neonatal mouse neuromuscular junctions are surprisingly resistant to hypoxic injury, but this resistance is rapidly lost after P10, leaving P21 mice very sensitive to even relatively short periods of hypoxic insult 33 . Further, hypoxia--reperfusion injury as occurs when the quality of tissue perfusion oscillates produces profound injury to motor nerve terminals while leaving skeletal muscle fibers relatively unscathed 34 . The pathological presentation of these injuries is not dissimilar from the motor nerve terminal damage seen as one of the earliest pathological features in SMA 16 . A very recent report has shown that post--natal hypoxia significantly stunts growth and negatively modulates motor function 35 . Taken together, these studies point toward possible disease mechanisms.
Conserved vascular defects are present in human severe SMA patients and mouse models of severe SMA
We were keen to determine whether the data from the two mouse models of severe SMA accurately predicted vascular defects in SMA patients. Type I/II patient skeletal muscle biopsies showed muscle atrophy as expected (Fig 2B) 36 the notion that therapies directed solely at the nervous system, may ultimately uncover additional non--neuronal pathologies 3 . This also further argues for the importance of systemic treatment approaches, particularly in severe SMA, as suggested by recent SMN viral delivery and oligonucleotide studies 9, 10 . Taken together, these data provide support for the idea that severe SMA mice are reliable models in which to study both the development and treatment of significant, vascular pathology in severe SMA patients.
Spinal cord capillary beds fail to develop normally in the early post--natal period
The pathological hallmark of SMA is the profound loss of spinal motor neurons. With this in mind, we investigated the blood supply of the spinal cord and showed that capillaries fail to develop normally in severe SMA mice. They do not show the rapid increase in density, brought about by active angiogenesis, which occurs in white, and more strikingly, in grey matter in littermate controls. This results in SMA ventral grey matter having less than half the normal density of capillaries (Fig 4B,C) . Embryonic development appears unaffected, as there are no differences at birth, rather a failure to develop in the postnatal period after birth is suggested. Specifically, growth of the capillary bed in SMA mice barely keeps pace with the growth of the spinal cord, resulting in a consistently low density. This contrasts with unaffected littermates where capillary growth outstrips spinal cord growth resulting in significantly increased density. Importantly, this is also the case in a second mouse model of SMA and specifically one generated using a different transgenic strategy to include the delta 7 transgene and thereby avoiding positional effects (Fig 4H,I) .
This reduction in capillary density could contribute to the pathogenesis of SMA, particularly the degeneration of motor neurons. A 10--15% reduction in the total length and number of spinal cord capillaries results in a 30--45% reduction in spinal cord blood flow 37 . A similar decreased perfusion of the cord occurs rapidly subsequent to spinal cord injury 38 , and leads to motor neuron degeneration 39 .
Early symptomatic severe mouse SMA spinal cord is significantly hypoxic
Given the importance of oxygenation for cell survival, we directly measured hypoxia in early symptomatic spinal cord. In SMA, significant numbers of hypoxic cells were present throughout spinal cord, and specifically there was an increase in the number of hypoxic large, Nissl--positive (likely) motor neurons at this early symptomatic time-point in ventral spinal cord (Fig 5B,C,D) . PIMO stain indicated oxygen concentrations less than 30% of normal levels in the CNS. This tissue hypoxia was observed at an early stage in disease progression (P5), which is prior to or in--line with the appearance of neuromuscular pathology 25 15 . Patient autopsies show markers of oxidative stress in the motor neurons and brains of SMA patients 40 and oxidative stress is a major cause of motor neuron death in clinically similar ALS 41, 42 . PIMO is rapidly cleared from the body by urinary excretion and therefore kidney function in SMA mice is a relevant consideration. Only one study has directly assessed renal function in the Taiwanese severe mouse model, and they found no significant differences in two key markers of renal function: urea nitrogen and creatinine in blood 43 . We therefore conclude that it is unlikely that altered renal function has biased our interpretation of PIMO data in SMA mouse spinal cord.
The final form of the normal vascular system is widely considered to be barely sufficient for the functioning of a healthy CNS 44 and given the relatively high metabolic needs of the CNS 45 , the likely effects of chronic hypoxia due to hypovascularity are significant. Deletion of the hypoxia response element in mice, diminished vascular perfusion and triggered degeneration of 30% of ventral horn motor neurons 39 . These mice presented with severe muscle weakness and an ALS-phenotype with hindlimb clasping, muscle weakness and progressive immobility 39 .
Hypoxia is therefore demonstrated to be a risk factor in triggering motor neuron degeneration, and likely contributes to motor pathology in SMA.
Spinal cord hypoxia is predicted to have additional, negative effects on disease progression
Aside from obvious deleterious effects on cell metabolism and survival, hypoxia also has a negative effect upon SMN splicing, by increasing levels of exon 7 skipping in the SMN2 gene 46 , which would be expected to result in further depletion of SMN levels in hypoxic tissue. This suggests that hypoxia could be a major modulator of SMN protein levels, the main determinant of disease severity 47 . Furthermore it has been shown that reactive oxygen species, generated during hypoxia, inhibit SMN complex activity in a dose--dependent manner; specifically it is proposed that SMNΔ7, the major protein product of SMN2 may be particularly vulnerable to oxidative stress 48 . Major changes in gene transcription occur in the SMA late symptomatic spinal cord 49 , suggestive of significant, ongoing developmental anomalies such as these. A situation may therefore exist whereby reduced SMN protein levels induce a hypoxic state due to morphological vascular defects, which in turn causes a reduction in SMN protein levels and further exacerbates disease progression.
The protein composition of the blood spinal cord barrier is defective in SMA mice
The blood brain barrier is key to maintain the 'protected' status of the CNS. In SMA only Claudin--5, a component of endothelial cell tight junctions, did not completely co--localise with blood vessels, particularly in smaller vessels (Fig 6) , suggesting incomplete formation of the BSCB. Once again, this indicates a post--natal failure in development and maturation of blood vessels, where the smallest and presumed recently formed vessels do not acquire full barrier properties.
Mice maintained in hypoxic conditions develop a 41% decrease in Claudin--5 protein expression, in the blood retinal barrier, resulting in leakage 50 . We suggest that the hypoxia we see at P5 has at least partly driven the defects observed in the BSCB at P11. The particular sensitivity of Claudin--5 to hypoxia could explain why it appears to be the only BSCB component affected in SMA. This could in turn be a factor in motor neuron damage resulting via a leaky BSCB 30 .
Changing perceptions
SMA has traditionally been viewed as a disease of lower motor neurons, with the development of therapeutic interventions for many years focused on maintaining or replacing motor neurons 51 , based on the concept that they are selectively vulnerable 16 . Our data suggest that hypoxia, driven by primary vascular defects, may contribute to this vulnerability. Here, motor neurons become highly active in the post--natal period and oxygen demand is not met by a defective vasculature, leading to metabolic failure and the production of oxygen radicals, which together result in motor neuron dysfunction and death. Added to this the negative effects of hypoxia 
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